BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27573813)

  • 1. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1.
    Guo H; Cranert SA; Lu Y; Zhong MC; Zhang S; Chen J; Li R; Mahl SE; Wu N; Davidson D; Waggoner SN; Veillette A
    J Exp Med; 2016 Sep; 213(10):2187-207. PubMed ID: 27573813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant deletion of SLAM-family receptors, NKG2D and DNAM-1 reveals gene redundancy of NK cell activating receptors in NK cell development and education.
    Chen S; Dong Z
    J Leukoc Biol; 2020 Apr; 107(4):561-572. PubMed ID: 31729776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
    Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
    Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Self-Specific Activation Receptor SLAM Family Is Critical for NK Cell Education.
    Chen S; Yang M; Du J; Li D; Li Z; Cai C; Ma Y; Zhang L; Tian Z; Dong Z
    Immunity; 2016 Aug; 45(2):292-304. PubMed ID: 27521267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell regulation by SLAM family receptors and SAP-related adapters.
    Veillette A
    Immunol Rev; 2006 Dec; 214():22-34. PubMed ID: 17100873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
    Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
    Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.
    Alari-Pahissa E; Grandclément C; Jeevan-Raj B; Leclercq G; Veillette A; Held W
    PLoS One; 2016; 11(4):e0153236. PubMed ID: 27054584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48.
    Li R; Galindo CC; Davidson D; Guo H; Zhong MC; Qian J; Li B; Ruzsics Z; Lau CM; O'Sullivan TE; Vidal SM; Sun JC; Veillette A
    Cell Rep; 2024 Mar; 43(3):113800. PubMed ID: 38386559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MHC class I-independent NK cell education by SLAM family receptors.
    Chen S; Li D; Wang Y; Li Q; Dong Z
    Adv Immunol; 2020; 145():159-185. PubMed ID: 32081197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
    Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
    Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation.
    Sandusky MM; Messmer B; Watzl C
    Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell recognition of hematopoietic cells by SLAM-SAP families.
    Chen S; Dong Z
    Cell Mol Immunol; 2019 May; 16(5):452-459. PubMed ID: 30911116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
    Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
    Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity.
    Marchitto L; Benlarbi M; Prévost J; Laumaea A; Descôteaux-Dinelle J; Medjahed H; Bourassa C; Gendron-Lepage G; Kirchhoff F; Sauter D; Hahn BH; Finzi A; Richard J
    mBio; 2023 Aug; 14(4):e0078923. PubMed ID: 37404017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
    Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
    J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.
    Graham DB; Bell MP; McCausland MM; Huntoon CJ; van Deursen J; Faubion WA; Crotty S; McKean DJ
    J Immunol; 2006 Jan; 176(1):291-300. PubMed ID: 16365421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family.
    Velikovsky CA; Deng L; Chlewicki LK; Fernández MM; Kumar V; Mariuzza RA
    Immunity; 2007 Oct; 27(4):572-84. PubMed ID: 17950006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis.
    Waggoner SN; Taniguchi RT; Mathew PA; Kumar V; Welsh RM
    J Clin Invest; 2010 Jun; 120(6):1925-38. PubMed ID: 20440077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.